Intravenous propofol shortens sinus cycle length and facilitates atrioventricular nodal conduction without interfering with radiofrequency catheter ablation in patients with tachyarrhythmia

S. W. Lai, H. M. Yeh, J. L. Lin, Y. N. Lin, G. T. Lin

Research output: Contribution to journalArticle

Abstract

Background. Propofol is now widely used as an intravenous anesthetic. The present study was performed to determine the effects of propofol on cardiac electrophysiologic properties and radiofrequency catheter ablation (RFCA) procedure in patients with tachyarrhythmia. Methods. Twenty-one were included, all consecutive patients undergoing RFCA for various tachyarrhythmias, including atrioventricular nodal reentrant tachycardia in 7, atrioventricular reciprocating tachycardia in 13 (4 with manifest and, 9 with concealed, accessory pathway) and idiopathic left ventricular tachycardia in 1. Continuous infusion, without loading, of propofol at 100 to 120 μg/kg/minute introduced smooth general anesthesia and stable 94-99% oxygen saturation without artificial ventilation. The electrophysiologic properties and the tachycardia inducibility were measured before and during propofol infusion. RFCA was then performed. Results. During propofol infusion, there was a significantly shorter sinus cycle length when compared to that before propofol infusion. The atrioventricular nodal conduction, both antegrade and retrograde, were facilitated. These changes were associated with a reduction of systolic, diastolic and mean arterial blood pressure. The accessory pathway effective refractory period, as well as the sinus node recovery time, atrial effective refractory period, ventricular effective refractory period were not significantly changed. All the tachycardias remained inducible during propofol infusion. RFCA was successfully performed in all patients. Conclusion. Propofol infusion increased sinus heart rate and facilitated atrioventricular nodal conduction. All the tachyarrhythmias remained inducible after propofol infusion, and the RFCA were performed smoothly or without may active effect.

Original languageEnglish
Pages (from-to)190-194
Number of pages5
JournalActa Cardiologica Sinica
Volume12
Issue number4
Publication statusPublished - Dec 1 1996
Externally publishedYes

Fingerprint

Catheter Ablation
Propofol
Tachycardia
Arterial Pressure
Reciprocating Tachycardia
Accessory Atrioventricular Bundle
Atrioventricular Nodal Reentry Tachycardia
Intravenous Anesthetics
Sinoatrial Node
Ventricular Tachycardia
General Anesthesia
Heart Rate
Oxygen

Keywords

  • propofol
  • radiofrequency catheter ablation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{eed96d09cfb54ec99c254880b25e7c57,
title = "Intravenous propofol shortens sinus cycle length and facilitates atrioventricular nodal conduction without interfering with radiofrequency catheter ablation in patients with tachyarrhythmia",
abstract = "Background. Propofol is now widely used as an intravenous anesthetic. The present study was performed to determine the effects of propofol on cardiac electrophysiologic properties and radiofrequency catheter ablation (RFCA) procedure in patients with tachyarrhythmia. Methods. Twenty-one were included, all consecutive patients undergoing RFCA for various tachyarrhythmias, including atrioventricular nodal reentrant tachycardia in 7, atrioventricular reciprocating tachycardia in 13 (4 with manifest and, 9 with concealed, accessory pathway) and idiopathic left ventricular tachycardia in 1. Continuous infusion, without loading, of propofol at 100 to 120 μg/kg/minute introduced smooth general anesthesia and stable 94-99{\%} oxygen saturation without artificial ventilation. The electrophysiologic properties and the tachycardia inducibility were measured before and during propofol infusion. RFCA was then performed. Results. During propofol infusion, there was a significantly shorter sinus cycle length when compared to that before propofol infusion. The atrioventricular nodal conduction, both antegrade and retrograde, were facilitated. These changes were associated with a reduction of systolic, diastolic and mean arterial blood pressure. The accessory pathway effective refractory period, as well as the sinus node recovery time, atrial effective refractory period, ventricular effective refractory period were not significantly changed. All the tachycardias remained inducible during propofol infusion. RFCA was successfully performed in all patients. Conclusion. Propofol infusion increased sinus heart rate and facilitated atrioventricular nodal conduction. All the tachyarrhythmias remained inducible after propofol infusion, and the RFCA were performed smoothly or without may active effect.",
keywords = "propofol, radiofrequency catheter ablation",
author = "Lai, {S. W.} and Yeh, {H. M.} and Lin, {J. L.} and Lin, {Y. N.} and Lin, {G. T.}",
year = "1996",
month = "12",
day = "1",
language = "English",
volume = "12",
pages = "190--194",
journal = "Acta Cardiologica Sinica",
issn = "1011-6842",
publisher = "Republic of China Society of Cardiology",
number = "4",

}

TY - JOUR

T1 - Intravenous propofol shortens sinus cycle length and facilitates atrioventricular nodal conduction without interfering with radiofrequency catheter ablation in patients with tachyarrhythmia

AU - Lai, S. W.

AU - Yeh, H. M.

AU - Lin, J. L.

AU - Lin, Y. N.

AU - Lin, G. T.

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Background. Propofol is now widely used as an intravenous anesthetic. The present study was performed to determine the effects of propofol on cardiac electrophysiologic properties and radiofrequency catheter ablation (RFCA) procedure in patients with tachyarrhythmia. Methods. Twenty-one were included, all consecutive patients undergoing RFCA for various tachyarrhythmias, including atrioventricular nodal reentrant tachycardia in 7, atrioventricular reciprocating tachycardia in 13 (4 with manifest and, 9 with concealed, accessory pathway) and idiopathic left ventricular tachycardia in 1. Continuous infusion, without loading, of propofol at 100 to 120 μg/kg/minute introduced smooth general anesthesia and stable 94-99% oxygen saturation without artificial ventilation. The electrophysiologic properties and the tachycardia inducibility were measured before and during propofol infusion. RFCA was then performed. Results. During propofol infusion, there was a significantly shorter sinus cycle length when compared to that before propofol infusion. The atrioventricular nodal conduction, both antegrade and retrograde, were facilitated. These changes were associated with a reduction of systolic, diastolic and mean arterial blood pressure. The accessory pathway effective refractory period, as well as the sinus node recovery time, atrial effective refractory period, ventricular effective refractory period were not significantly changed. All the tachycardias remained inducible during propofol infusion. RFCA was successfully performed in all patients. Conclusion. Propofol infusion increased sinus heart rate and facilitated atrioventricular nodal conduction. All the tachyarrhythmias remained inducible after propofol infusion, and the RFCA were performed smoothly or without may active effect.

AB - Background. Propofol is now widely used as an intravenous anesthetic. The present study was performed to determine the effects of propofol on cardiac electrophysiologic properties and radiofrequency catheter ablation (RFCA) procedure in patients with tachyarrhythmia. Methods. Twenty-one were included, all consecutive patients undergoing RFCA for various tachyarrhythmias, including atrioventricular nodal reentrant tachycardia in 7, atrioventricular reciprocating tachycardia in 13 (4 with manifest and, 9 with concealed, accessory pathway) and idiopathic left ventricular tachycardia in 1. Continuous infusion, without loading, of propofol at 100 to 120 μg/kg/minute introduced smooth general anesthesia and stable 94-99% oxygen saturation without artificial ventilation. The electrophysiologic properties and the tachycardia inducibility were measured before and during propofol infusion. RFCA was then performed. Results. During propofol infusion, there was a significantly shorter sinus cycle length when compared to that before propofol infusion. The atrioventricular nodal conduction, both antegrade and retrograde, were facilitated. These changes were associated with a reduction of systolic, diastolic and mean arterial blood pressure. The accessory pathway effective refractory period, as well as the sinus node recovery time, atrial effective refractory period, ventricular effective refractory period were not significantly changed. All the tachycardias remained inducible during propofol infusion. RFCA was successfully performed in all patients. Conclusion. Propofol infusion increased sinus heart rate and facilitated atrioventricular nodal conduction. All the tachyarrhythmias remained inducible after propofol infusion, and the RFCA were performed smoothly or without may active effect.

KW - propofol

KW - radiofrequency catheter ablation

UR - http://www.scopus.com/inward/record.url?scp=0030429141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030429141&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030429141

VL - 12

SP - 190

EP - 194

JO - Acta Cardiologica Sinica

JF - Acta Cardiologica Sinica

SN - 1011-6842

IS - 4

ER -